Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2004 Jun;71(6):559-61.
doi: 10.1007/BF02724305.

Recurrent acute transverse myelopathy: association with antiphospholipid antibody syndrome

Affiliations
Case Reports

Recurrent acute transverse myelopathy: association with antiphospholipid antibody syndrome

Vijaya Shaharao et al. Indian J Pediatr. 2004 Jun.

Abstract

A seven-year-old boy presented with a second episode of acute transverse myelopathy. The first episode had responded dramatically to methylprednisolone. The manifestations of the second episode did not respond to methylprednisolone or IVIG. He showed persistently raised levels of antiphospholipid antibodies in the serum. Primary conditions like collagen vascular diseases, malignancy, exposure to drugs and HIV infection, which are known to be associated with the raised titers of these antibodies were ruled out clinically and by investigations. Recurrent transverse myelopathy is a rare event in childhood and reports of its association with Antiphospholipid Antibody Syndrome (APLAS) are scanty. The etiological role for these antibodies remains to be established. However, once the diagnosis is established, it may be prudent to treat the condition with agents and procedures to bring about a decrease in their titers. Long-term therapy to prevent thromboembolic complications of APLAS may also be instituted.

PubMed Disclaimer

References

    1. AJNR Am J Neuroradiol. 1998 Apr;19(4):781-6 - PubMed
    1. Lupus. 1998;7(1):49-50 - PubMed
    1. J Rheumatol. 1998 Jul;25(7):1425-8 - PubMed
    1. J Neurol. 1986 Jun;233(3):185-7 - PubMed
    1. J Neurol Sci. 1996 Aug;139(2):235-7 - PubMed

Publication types

Substances